The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| BCPC | -5.49% | +53.46% | +8.94% | +75,998% |
| S&P | +16.23% | +94.45% | +14.22% | +2,645% |
Balchem Corp. provides marketing of specialty performance ingredients and products. It operates through the following segments: Human Nutrition and Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health segment supplies ingredients in the food and beverage industry, providing customized solutions in powder, solid and liquid flavor delivery systems, spray dried emulsified powder systems, and cereal systems. The Animal Nutrition and Health segment comprises nutritional products derived from microencapsulation and chelation technologies in addition to basic choline chloride. The Specialty Products segment offers Ethylene oxide for the health care industry. The Industrial Products segment refers to certain derivatives of choline chloride which manufactured and sold into industrial applications as a component for hydraulic fracturing of shale natural gas wells. The company was founded in January 1967 and is headquartered in Montvale, NJ.
This behind-the-scenes nutrition company is capitalizing on "better for you" trends.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $267.56M | 11.5% |
| Gross Profit | $95.45M | 11.8% |
| Gross Margin | 35.68% | 0.1% |
| Market Cap | $4.87B | -14.7% |
| Market Cap / Employee | $3.57M | 0.0% |
| Employees | 1.4K | 0.0% |
| Net Income | $40.29M | 19.1% |
| EBITDA | $66.46M | 12.4% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $65.09M | -11.7% |
| Accounts Receivable | $128.49M | 6.6% |
| Inventory | 132.4 | 11.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $167.85M | -30.6% |
| Short Term Debt | $4.15M | 21.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 9.16% | 1.6% |
| Return On Invested Capital | 8.61% | 0.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $50.67M | 20.2% |
| Operating Free Cash Flow | $65.57M | 27.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 41.43 | 39.75 | 36.48 | 32.85 | -30.51% |
| Price to Book | 4.50 | 4.70 | 4.30 | 3.84 | -20.96% |
| Price to Sales | 5.56 | 5.65 | 5.28 | 4.83 | -21.18% |
| Price to Tangible Book Value | 24.24 | 26.36 | 20.80 | 17.42 | -33.46% |
| Price to Free Cash Flow TTM | 43.93 | 44.47 | 41.69 | 36.69 | -12.88% |
| Enterprise Value to EBITDA | 94.94 | 89.64 | 84.51 | 75.20 | -25.17% |
| Free Cash Flow Yield | 2.3% | 2.2% | 2.4% | 2.7% | 14.79% |
| Return on Equity | 11.7% | 11.9% | 12.0% | 12.1% | 9.24% |
| Total Debt | $208.04M | $208.07M | $207.68M | $172.00M | -29.88% |
BCPC earnings call for the period ending June 30, 2022.
BCPC earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
